The global life science instrumentation market was valued at US$ 60.85 billion in 2021 and is expected to reach over US$ 106.39 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 5.4% from 2021 to 2030.
The life science instruments are commonly utilized for analytical techniques and method validation during drug development. Nowadays, several innovative technologies are used in the medication development process. The life science instrumentation market will benefit from rising demand for analytical instruments, strong growth in the biotechnology and pharmaceutical industries, and expanding application area of analytical instruments. As sequencing technologies aids in determining the origin of an illness, increased attention on next generation sequencing (NGS) is expected to promote market growth.
The life science instrumentation market is expected to benefit from an increase in research and development activities in various sectors such as biotechnology, pharmaceuticals, food and beverage, and agriculture. Moreover, the increased number of novel product launches by numerous prominent players is expected to boost the growth of the life science instrumentation market during the forecast period.
The growing incidence of chronic diseases in both developing and developed countries is projected to increase the demand for effective technology for early disease diagnosis, which will drive up the demand for instruments in life science. Furthermore, the market for life science instrumentation is being driven by increased public-private investments in life science research and technical developments in analytical equipment. However, the high cost of life science instrumentation is inhibiting the market’s expansion.
During the forecast period, the life science instrumentation market is expected to rise due to rising demand for effective diagnostic technologies and increasing government funding in the development of new instruments utilized in the life sciences and medical devices sectors. The growing applications of life science instruments in other industries, such as the food and beverage industry is expected to boost the life science instrumentation market growth during the forecast period.
The majority of life science and analytical technologies are utilized to study DNA in order to develop new pharmaceutical medications and determine food quality. The companies are heavily investing in this area in order to increase the market growth. The development of new products will improve the ability to accurately diagnose samples. It will assist in the targeting of treatment for a specific patient.
The growth of life science instrumentation market is projected to be hampered by high maintenance and operation costs. In addition, without an alternative, diagnosing the samples will be difficult because the lack of such intricate equipment would make the process much more complicated and cause the outcome to be delayed.
Scope of the Life Science Instrumentation Market
|Market Size in 2020||US$ 57.5 Billion|
|Growth Rate From 2021 to 2030||CAGR of 5.4%|
|Revenue Projection by 2030||US$ 106.39 Billion|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Forecast Period||2021 to 2030|
|Companies Mentioned||Bruker Corporation, Eppendorf AG, Hitachi High Technologies Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Waters Corporation, Thermo Fisher Scientific, Agilent Technologies, Shimadzu Corporation, Qiagen N.V.|
Based on the technology, the next generation sequencing (NGS) segment dominates the life science instrumentation market during the forecast period. The next generation sequencing (NGS) segment is predicted to increase at the fastest CAGR throughout the forecast period, owing to the benefits of NGS technologies in DNA sequencing, which give much higher productivity and reduce the requirement for fragment-cloning processes. Moreover, the constant technological developments and the rising availability of less expensive sequencing platforms are likely to fuel the expansion of the life science instrumentation market.
The microscopy is expected to grow at rapid pace during the forecast period. The expanding healthcare sector, combined with rising applications from emerging economies, would further boost numerous prospects that will contribute to the development of the microscopy segment.
Based on the application, the research dominates the life science instrumentation market during the forecast period. The expanding number of research studies along with increased public-private funding in the field of genomic researches, as well as the continued trend of laboratory automation and robotics, all contributes to the substantial share of the research applications segment.
The clinical segment is expected to grow at rapid pace during the forecast period. The rising frequency of chronic disease, as well as the expanding demand for clinical trials in emerging countries, is driving the growth of segment.
End User Insights
Based on the end user, the pharma-biotech dominate the life science instrumentation market during the forecast period. The life science instruments are used widely in pharmaceutical and biotechnology industries. Pharmaceutical instrumentation necessitates the highest levels of precision, dependability, and quality.
The hospitals & diagnostic labs is expected to grow at rapid pace during the forecast period. The utilization of life science instrumentation in diagnostic labs and hospitals is on a large scale, owing to rising prevalence of chronic diseases and rising R&D investments.
Based on the region, the North America segment dominated the global life science instrumentation market in 2020, in terms of revenue and is estimated to sustain its dominance during the forecast period. The life science instrumentation is employed in a variety of applications in North America. The life science instrumentation has shown to be a useful tool for a variety of applications including pharmaceutical applications, final product testing, and food safety testing.
On the other hand, in the life science instrumentation market, the Asia-Pacific region is one of the most profitable regions. The region’s growth is being fueled by strategic expansions by important market players in rising Asian countries, the growing pharmaceutical industry in China and India.
Key Companies & Market Share Insights
The market growth strategies such as acquisitions, mergers, and collaborations are being used by key market players in the life science instrumentation market to expand their product portfolios. Only a few firms have come up with innovative technologies and new product launches.
Tecan Trading AG introduced NGS DreamPre in February 2019, a fully automated approach to next generation sequencing (NGS) that produces quality-controlled, sequencing-ready NGS libraries in a matter of hours with no operator interaction and no sample loss.
Some of the key market players in the global life science instrumentation market include:
Segments Covered in the Report
By End User
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client